[Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
Arion
V Ia
VIa
Bekman
E M
EM
Tiurin
N A
NA
Mazurina
N A
NA
Filimonova
A V
AV
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000287:Administration, Topical; D001424:Bacterial Infections / Q000150:complications; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000628:therapy*; D007223:Infant; D007279:Injections, Subcutaneous; D008297:Male; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D013949:Thymus Extracts / Q000008:administration & dosage / Q000627:therapeutic use*; D014777:Virus Diseases / Q000150:complications
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Sravneneie éffektivnosti nakozhnogo i podkozhnogo vvedeniĭ taktivina s tsel'iu korektsii vtorichnogo immunodefitsitnogo sostoianiia u deteĭ rannego vozrasta.